Nectar Lifesciences Ltd. - Research Center
532649 NECLIFE Group (B) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
22.43 |
22.43 |
22.43 |
22.43 |
22.43 |
Share application money
Preference share capital
Reserves & surplus
1,042.17 |
1,064.44 |
1,038.31 |
1,112.18 |
1,082.21 |
Secured loans
753.83 |
859.93 |
840.24 |
741.20 |
780.04 |
Unsecured loans
Total
1,818.42 |
1,946.79 |
1,900.97 |
1,875.80 |
1,906.20 |
Gross block
1,425.16 |
1,439.15 |
1,439.80 |
1,404.86 |
1,399.79 |
Less : revaluation reserve
Less : accumulated depreciation
763.18 |
716.06 |
667.91 |
620.01 |
574.98 |
Net block
661.97 |
723.10 |
771.89 |
784.85 |
824.82 |
Capital work-in-progress
77.78 |
85.10 |
98.63 |
115.00 |
99.55 |
Investments
Current assets, loans & advances
1,448.90 |
1,580.48 |
1,598.65 |
1,731.58 |
1,778.30 |
Less : current liabilities & provisions
370.79 |
442.92 |
569.22 |
756.37 |
797.58 |
Total net current assets
1,078.11 |
1,137.56 |
1,029.43 |
975.22 |
980.72 |
Miscellaneous expenses not written
Total
1,818.42 |
1,946.79 |
1,900.97 |
1,875.80 |
1,906.20 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
164.80 |
76.77 |
93.25 |
75.71 |
53.17 |
Number of equity sharesoutstanding (Lacs)
2242.61 |
2242.61 |
2242.61 |
2242.61 |
2242.61 |